InflaRx (IFRX) Gross Profit (2023 - 2026)

InflaRx's (IFRX) quarterly Gross Profit came in at $10877.4 in Q1 2026, up 100.0% year-on-year from $5438.7 in Q1 2025, and up 100.19% quarter-over-quarter from -$5.7 million in Q4 2025.

InflaRx (IFRX) Gross Profit (2023 - 2026) Analysis & Trends

InflaRx has disclosed Gross Profit across 4 years of filings, most recently posting $10877.4 for Q1 2026.

  • Gross Profit for Q1 2026 came in at $10877.4, up 100.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.6 million (up 99.91% YoY), and the FY2025 annual result was -$8.4 million, down 150.21% from the prior year.
  • Gross Profit came in at $10877.4 for Q1 2026 at InflaRx, up from -$5.7 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $215661.8 in Q3 2024 to a low of -$9.8 billion in Q1 2025.
  • The 4-year median for Gross Profit is -$295732.8 (2023), against an average of -$889.6 million.
  • Across the five-year window, Gross Profit jumped 201.95% in 2024 and tumbled 4876277.42% in 2025, its largest moves.
  • InflaRx's Gross Profit stood at -$295732.8 in 2023, then plunged by 919.46% to -$3.0 million in 2024, then plunged by 88.89% to -$5.7 million in 2025, then surged by 100.19% to $10877.4 in 2026.
  • The last three Gross Profit figures came in at $10877.4 (Q1 2026), -$5.7 million (Q4 2025), and -$202102.7 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40

Historic Data

Download Data
DateValue
Mar 31, 2026 10,877.40
Mar 31, 2026 10,877.40
Dec 31, 2025 -5.69 Mn
Dec 31, 2025 -5.69 Mn
Sep 30, 2025 -202,102.74
Sep 30, 2025 -202,102.74
Jun 30, 2025 -2.67 Mn
Jun 30, 2025 -2.67 Mn
Mar 31, 2025 -9.77 Bn
Mar 31, 2025 -9.77 Bn
Dec 31, 2024 -3.01 Mn
Dec 31, 2024 -3.01 Mn
Sep 30, 2024 215,661.76
Sep 30, 2024 215,661.76
Jun 30, 2024 -368,075.87
Jun 30, 2024 -368,075.87
Mar 31, 2024 -200,416.36
Mar 31, 2024 -200,416.36
Dec 31, 2023 -295,732.84
Dec 31, 2023 -295,732.84